Quote:Obama Launches Into Blistering Attack On The ‘Swamp of Crazy’ That Created Trump
'Swamp of Crazy', beautiful! Nothing whatsoever to walk back, a swamp full of baskets of deplorables. Squeal away over it, righty mf's!
By Sean Colarossi on Thu, Oct 13th, 2016 at 8:58 pm
"[Trump] didn't build this house by himself. He just slapped his name on it and took credit for it," the president said.
At the Ohio Democratic Party State Dinner in Columbus on Thursday, President Obama launched into a blistering attack on Donald Trump and slammed the “swamp of crazy” within the Republican Party that helped create him.
Obama also took aim at comments Trump was heard making in a 2005 ‘Access Hollywood’ video, saying “no decent person” would even think the things Trump said.
But he didn’t just slam Trump. Obama also went directly after Republicans who have spent the campaign supporting him and are only now deciding to abandon him – when it’s politically convenient.
Obama said:
They know better, a lot of these folks who ran, and they didn’t say anything. So they don’t get credit for, at the very last minute when finally the guy that they nominated and they endorsed and they supported, is caught on tape saying things that no decent person would even think, much less say, much less brag about, much less laugh about or joke about … You can’t wait until that finally happens and then say, “Oh, that’s too much, that’s enough,” and think that somehow you’re showing any kind of leadership and deserve to be elected…You don’t get points for that.
Obama also went straight after the GOP’s hypocrisy when it comes to supporting a man like Trump, and tied all Republicans up and down the ballot to their nominee.
“You claim the mantle of the party of family values, and this is the guy you nominate and stand by and endorse and campaign with?” Obama said.
Of the culture of crazy in the Republican Party, Obama said, “Don’t act like this started under Donald Trump.”
The president instead blamed years of ridiculous conspiracies and vicious attacks on him for the eventual nomination of Donald Trump – a man who is essentially the embodiment of nearly a decade of GOP lunacy.
As Trump implodes and is increasingly unlikely to become the next president, Obama went for the jugular and tried to take the GOP – the party that has aided and abetted Trump for over a year – down with their unfit nominee.
Obama Launches Into Blistering Attack On The ‘Swamp of
Top 10 Most Recent News Articles
Local Visibility Crisis Looms for Small Businesses
Scrolling through these fresh stats from BrightLocal's recent report, you can almost hear the alarm bells echoing across small towns and city squares. The data paints a surprisingly sobering picture: despite the fact that 71% of folks are heading straight to Google to find local businesses, only a mere 22% of small business owners are tagging it as one of their top tools...
Continue ReadingCasio Unveils Analog G-SHOCKs with Iconic Style
Blending the Old with the New Here's an interesting tidbit for all you watch aficionados and investors: Casio is set to drop the GMC-2500 and GAC-2500, a new wave of G-SHOCK watches that are marrying that vintage cool with today's swagger. Straight out of Tokyo, these timepieces are taking a page from the 1983 DW-5000C playbook, but the twist? They're going analog. It's a...
Continue Reading
Equity Alerts: Unraveling the Latest M&A Surprises
Diving Into the M&A Controversy On the bustling streets of New York, beneath the towering Empire State Building, a plot unfolds that could shake the foundations of your investments—particularly if you're holding shares in Synaptics, Eagle Financial, Victory Capital, or Centerspace. Juan Monteverde and his legal firepower from Monteverde & Associates PC are launching a...
Continue Reading
Rznomics Advances with EU Orphan Status for RZ-001
RZ-001's European Success: A New Frontier Look, when a biopharmaceutical firm's RNA-editing therapy snags an Orphan Medicinal Product Designation from the European Commission, it's not just some clipboard milestone—it's a heavy-hitter move. That's exactly what Rznomics, the South Korean gene therapy player, pulled off with RZ-001. Now, we aren't just seeing paperwork...
Continue Reading
American Lung Association's Push for Biomarker Testing
Lung Cancer's Unseen Struggles and a Ray of Hope Not every day we get a chance to chew on the news of another initiative by the American Lung Association. They're ringing the bell again this year, focusing on the underutilized biomarker testing that could be the ticket to a longer life for lung cancer patients. When you dive into the stark figures, it hits hard. More than...
Continue Reading
Labcorp Scoops Up BioReference Health For $722M+
Picture this: You’re a big fish like Labcorp ready to feast on smaller catches. That’s exactly what’s rolling out as OPKO Health cuts a deal to offload a chunk of its BioReference Health assets to Labcorp for a tidy $722 million in cash. Assets on the Move OPKO’s BioReference Health has long been a player in the clinical testing world, with a focus on services...
Continue Reading
Bambu Lab Shakes Up 3D Printing with Massive Discounts
Price Cuts Bring 3D Printing Mainstream Here's the deal—3D printing used to be the domain of the tech-savvy elite, akin to those early computer geeks holed up in garages. But now? Bambu Lab is throwing open those doors with its Black Friday and Cyber Monday specials, slashing prices like a man on a mission. They're bringing an entire technological leap into our hands,...
Continue Reading
Highlight's Pulse Offers Real-Time Consumer Insights
Highlight Introduces Pulse for Instant Insights Ever find yourself waiting forever for consumer feedback? Well, folks, Highlight's making sure those days are behind us with their new launch: Pulse. They've taken the conventional consumer testing model and flipped it on its head with Highlight Twins. Imagine getting the pulse of your audience in mere seconds, not the...
Continue Reading
Amcor's Q3 2026 Results Loom: What's at Stake?
Anticipation Builds for Amcor's Q3 2026 Financials Well, here we are again, staring down the barrel of another quarterly earnings report from Amcor plc (NYSE: AMCR). They've circled November 4th, 2026, in red on their calendars to dish out the numbers after the U.S. market's last bell rings. Investors, analysts, and the peanut gallery will be tuning in, and why not? At a...
Continue Reading
Country Stars Illuminate Art in Philly, Mississippi
A Mural Tribute to Country Music Roots Forget about skyscrapers and bustling metropolises; sometimes, it's about bringing a bit of soul back to the heartland. That's precisely what the unveiling of the "Wildflowers and Wild Horses" mural in Philadelphia, Mississippi, did. Lainey Wilson and Marty Stuart's Vision Partners in crime — or, more fittingly, in country —...
Continue ReadingTop 5 Most Recently Viewed Articles
Thumzup Media Celebrates Nasdaq Listing with New Offerings
Thumzup Media Corporation Announces Its Nasdaq Listing Thumzup Media Corporation, known for revolutionizing social media branding, has recently made a significant move by listing its shares on Nasdaq. This exciting development allows Thumzup (OTCQB: TZUP) to broaden its reach and enhance its visibility in the competitive landscape of digital marketing. The company's...
Continue Reading
Lumene Group Transforms Cyber Safety for Brand Protection
Lumene Group Transforms Cyber Safety for Brand Protection Lumene Group has made significant advancements in its cybersecurity services in collaboration with Elisa. This innovative partnership focuses on protecting the company's brand integrity while actively monitoring for potential counterfeits. The updated cyber solutions include round-the-clock vigilance against cyber...
Continue Reading
J.B. Hunt's Stock Target Upgraded Amid Market Challenges
J.B. Hunt Stock Target Upgraded Recently, Bernstein SocGen Group made an important adjustment to its stock price target for J.B. Hunt Transport Services (NASDAQ: JBHT). The new target is set at $184.00, just slightly higher than the previous figure of $182.00. Despite this modest increase, the firm maintains a Market Perform rating on the company's stock. Market Analysis...
Continue Reading
Home Helpers Home Care Recognized as Top Franchise for Profitability
Home Helpers Home Care Achieves Prestigious Franchise Recognition Brand stands out among 75 franchises based on extensive research of over 35,000 franchise owners Home Helpers Home Care, a national leader in non-medical, in-home companionship and personal care services, has been honored with the title of one of the 2025 Most Profitable Franchises as recognized by...
Continue Reading
CSL's ANDEMBRY® Receives Health Canada Approval for HAE Care
CSL's ANDEMBRY® Gains Approval in Canada Health Canada has officially approved ANDEMBRY® (garadacimab) as the first and only once-monthly treatment for hereditary angioedema (HAE). This crucial advancement marks a significant step forward for individuals grappling with HAE, a rare genetic condition that can lead to severe and unpredictable swelling attacks. A New Era...
Continue Reading